Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 8.113% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) O=C(/C=C/c1ccccc1)N/C(=C/c1ccccc1)C(=O)Nc1cccc(C(=O)O)c1
b.) CCCCN(C(=O)c1ccc2ccccc2c1)c1c(N)n(CCCC)c(=O)[nH]c1=O
Answer: b. CCCCN(C(=O)c1ccc2ccccc2c1)c1c(N)n(CCCC)c(=O)[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(C(=O)c1ccc2ccccc2c1)c1c(N)n(CCCC)c(=O)[nH]c1=O
CCCCN(C(=O)c1ccc2ccccc2c1)c1c(N)n(CCCC)c(=O)[nH]c1=O
N-(6-amino-1-butyl-2,4-dioxopyrimidin-5-yl)-N-butylnaphthalene-2-carboxamide